Regulated information – Inside information – UCB announced that the companies have entered into a definitive agreement under which UCB would acquire Zogenix, Inc.,...
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), announced that a leading Italian pharmaceutical company selected ValGenesis VLMS – the...
The human gut is inhabited by a plethora of micro-organisms, collectively called the "microbiota," which are important for normal physiological processes. "Dysbiosis" or an...
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the Company will be presenting updated data from the DisTinGuish...
ImmunityBio, Inc, a clinical-stage immunotherapy company, announced interim results (N=63) in its metastatic pancreatic cancer trial (QUILT 88) showing that the overall survival rate...
